Skip to main content
. 2020 Dec 14;13:4427–4438. doi: 10.2147/IDR.S287934

Table 1.

Characteristics of Adverse Drug Events (194 ADEs Reported from 93 Individuals) Reported for Favipiravir in WHO Database

Parameters Frequency (%)
Age (N = 194) <18 Years 2 (1.03)
18–64 Years 131 (67.52)
≥65 Years 48 (24.74)
Not reported 13 (6.70)
Gender (N = 194) Female 75 (38.66)
Male 118 (60.82)
Not reported 1 (0.5)
The seriousness of ADE (N =194) Serious 63 (32.47)
Non-Serious 130 (67.01)
Not reported 1 (0.51)
Route of Administration (N =194) Oral 182 (93.81)
Unknown 8 (4.12)
Not reported 4 (2.06)
Dechallenge Action (N =194) Does not changed 14 (7.21)
Drug has withdrawn 29 (14.94)
Unknown 22 (11.34)
Not reported 129 (66.49)
Dechallenge Outcome (N =194) Fatal 1 (0.51)
No effect observed 7 (3.60)
Reaction abated 14 (7.21)
Effect unknown 19 (9.79)
Not Reported 153 (78.86)
Rechallenge Action (N=194) Rechallenge 3 (1.54)
Not Reported 191 (98.45)
Rechallenge Outcome (N=194) Effect unknown 3 (1.54)
Not Reported 191 (98.45)